Advanced Magnetic Resonance Imaging for Perioperative Evaluation of Dental, Oral and Maxillofacial Trauma
Launched by HARALD ESSIG · Jun 4, 2025
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients presenting with acute dental, oral and maxillofacial trauma
- • Age: 18 years and older
- • Able to give informed consent (documented by signature)
- • No prior radiation-based imaging for the current trauma episode
- Exclusion Criteria:
- • Pregnant or lactating individuals
- • Known contraindications to MRI (e.g., pacemakers, certain implants)
- • Clinically significant concomitant diseases affecting imaging quality (e.g., severe neurocognitive disorders)
- • Inability to comply with MRI procedures or study protocol (e.g., due to language barriers, psychological disorders, or dementia)
- • Participation in other clinical trials that may interfere with the imaging study
About Harald Essig
Harald Essig is a dedicated clinical trial sponsor specializing in innovative research and development within the pharmaceutical and biotechnology sectors. With a strong commitment to advancing medical science, the organization focuses on conducting rigorous clinical trials that adhere to the highest ethical and regulatory standards. Leveraging a team of experienced professionals and state-of-the-art methodologies, Harald Essig aims to accelerate the discovery and delivery of novel therapies, ultimately improving patient outcomes and enhancing public health. Through strategic partnerships and a patient-centric approach, the sponsor strives to contribute meaningfully to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported